Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review

Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review

Dyslipidaemia is one of the main causes of atherosclerotic cardiovascular disease (ASCVD) worldwide. Although statins remain the cornerstone of lipid-lowering therapy, many patients do not achieve optimal target levels of low-density lipoprotein cholesterol (LDL-C) due to intolerance or inadequate r...

Full description

Saved in:
Bibliographic Details
Main Authors: Dominik Strikic, Zvonimir Begic, Ivana Radman, Fran Zlopasa, Jana Mateljic, Ivica Zec, Marina Titlic, Ana Marija Sliskovic, Ivan Pecin, Zeljko Reiner, Iveta Mercep
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Biomedicines
Subjects:
dyslipidaemia
bempedoic acid
statin intolerance
cardiovascular risk
lipid-lowering therapy
Online Access:https://www.mdpi.com/2227-9059/13/6/1460
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/6/1460

Similar Items